Antidepressant use and resource utilization in the general practitioner setting in The Netherlands

Pharmacoepidemiology and Drug Safety

Volumn 7, Issue 4, 1998, Pages 253-260

  Pathiyal, Atul ^a   Hylan, Timothy R ^b,c,d   Quik, Ralph ^e   Jones, Judith K ^a  

^a The Degge Group Ltd   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d MIAMI UNIVERSITY   (United States)

^e Eli Lilly Nederland   (Netherlands)

Author keywords

Antidepressive agent; Computerized medical records systems; Drug utilization

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; MOCLOBEMIDE; NORTRIPTYLINE; OPIPRAMOL; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; DATA BASE; DEPRESSION; DRUG SAFETY; DRUG UTILIZATION; GENERAL PRACTITIONER; HEALTH CARE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL RECORD; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0031853431     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199807/08)7:4<253::AID-PDS362>3.0.CO;2-Y     Document Type: Article

References (22)

1. Anderson, I. M. and Tomenson, B. M. The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. Journal of Psychopharmacology, 1994; 8(4): 238-249.
2. Katon, W., Von Korff, M., Lin, E., Bush, T. and Ormel, J. Adequacy and duration of antidepressant treatment in primary care. Medical Care 1992; 30(1), 67-76.
3. Ormel, J., van den Brink, W., Koeter, M. W. J., et al. Recognition, management and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychological Medicine 1990; 30: 909-923.
4. Van Marwijk, H. W. J., Grudmeijer, H. G. L. M. and Brueren, M. M. NHG Standaard Depressie. Huisarts & Wetenshap 1994; 37(11): 482-490.
5. Kuy, A. van der. Farmacotherapeutisch Kompas 1996. Ziekenfondsraad, Amsterdam, the Netherlands, 1996.
6. Jones, J. K., Gorkin, L., Lian, J. F., Staffa, J. A. and Fletcher, A. P. Discontinuation of and change in treatment after start of new courses of antihypertensive drugs: study of a United Kingdom population. British Medical Journal, 1995; 311: 293-295.
7. IMD MIDAS Market Research, 1995.
8. De Waal, M., Stolk, J., van Marwijk, J. and Springer, M. Voorschrijven van antidepressiva in de huisartspraktijk. Nederlands Tijdschrift Geneeskund 1996; 140-143.
9. Orrell, M., Collins, E., Shergill, S. and Katona, C. Management of depression in the elderly by general practitioners: I. Use of antidepressants. Family Practice 1995; 12(1): 5-11.
10. Sclar, D. A., Robison, L. M., Skaer, T., et al. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine, and sertraline in a health maintenance organization. Journal of International Medical Research 1995; 23: 395-412.
11. Gregor, K. J., Overhage, M., Coons, S. J. and McDonald, R. C. Selective serotonin reuptake inhibitor dose titration in the naturalistic setting. Clinical Therapeutics 1994; 16(2): 306-315.
12. Simon, G. E., VonKorff, M., Wagner, E. H. and Barlow, W. Patterns of antidepressant use in community practice. General Hospital Psychiatry 1993; 15: 399-408.
13. Simon, G. E., Lin, E. H., Katon, W., et al. Outcomes of 'inadequate' antidepressant treatment. Journal of General Internal Medicine 1996; 10(12): 663-670.
14. Mintz, J., Mintz, L. I., Arruda, M. J. and Hwang, S. S. Treatments of depression and the functional capacity to work. Archives of General Psychiatry 1992; 49(10): 761-768.
15. Bingfors, K., Isacson, D., von Knorring, L. and Smedby, B. Prescription drug and Healthcare use among Swedish patients treated with antidepressants. Annuals of Pharmacotherapy 1995; 29: 566-572.
16. Simon, G. E., von Korff, M., Heiligenstein, J. H., et al. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs. tricyclic antidepressants. Journal of the American Medical Association 1996; 275(24): 1897-1902.
17. Johnson, D. Noncompliance with antidepressant therapy: an underestimated problem. Journal of Internal Medicine 1986; 11: 14-17.
18. Simon, G. E. and Von Korff, M. Recognition, management and outcomes of depression in primary care. Archives of Family Medicine 1995; 4(2): 99-105.
19. Rost, K., Smith, G. R., Matthews, D. B. and Guise, B. The deliberate misdiagnosis of major depression in primary care. Archives of Family Medicine 1994; 3: 333-337.
20. Gerber, P. D., Barrett, J., Manheimer, E., Whiting, R. and Smith, R. Recognition of depression by internists in primary care: a comparison of internist and 'gold standard' psychiatric assessments. Journal of General Internal Medicine 1989; 4(1): 7-13.
21. Rouillon, F., Blachier, C., Dreyfus, J. P., Bouhassira, M. and Allicar, M. P. Etude pharmaco-epidemiologique de la consommation des antidepresseurs en population generale. L'Encephale, 1996; Spring, 1: 39-48.
22. Bingefors, K., Isacson, D., von Knorring, L., Smedby, B., Ekselius, L. and Kupper, L. Antidepressant-treated patients in ambulatory care: long-term use of non-psychotropic and psychotropic drugs. British Journal of Psychiatry 1996; 168: 292-298.